Other Immunization Information
Immunization Branch |
![]() |
Cost-Benefit Analysis of Commonly Used Vaccines
Benefit-Cost Analysis of Commonly Used Vaccines |
||
---|---|---|
VACCINE |
DIRECT MEDICAL SAVINGS |
DIRECT + INDIRECT * SAVINGS |
DTaP |
$ 9.00 |
$27.00 |
MMR (includes 2nd dose) |
$14.20 |
$26.00 |
IPV |
$ 3.03 |
$ 5.45 |
H. INFLUENZAE TYPE b |
$ 3.40 |
$ 5.40 |
HEPATITIS B PERINATAL INFANT ADOLESCENT |
$1.40 $0.90 $0.50 |
$14.70 $5.10 $3.80 |
VARICELLA |
$ 0.90 |
$ 5.40 |
* Indirect savings include workloss, disability, and death
SOURCE: National Immunization Program, Centers for Disease Control and Prevention, October 2003
Required Record Keeping for Vaccinations
Record |
Legislation |
---|---|
Name and, if appropriate title of the health care provider who administers the vaccine Address where vaccine given (in the case of outreach clinics, address should be the clinic site where the record will reside) Date of vaccination Manufacturer and lot number of vaccine |
1986 National Childhood Vaccine Injury Act (NCVIA) 42 U.S.C. § 300aa-25 |
Edition (date of publication) of Centers for Disease Control and Prevention (CDC) Vaccine Information Statement (VIS)* provided and date provided. |
1994 amendment to 42 U.S.C. Sec. 2125. § 300aa-25 |
Site and route of administration |
Not required, but recommended. Information requested for reports to Vaccine Adverse Event Report System (VAERS). |
Licensure Dates for Vaccines and Toxoids, United States
VACCINE/TOXOID |
DATE |
---|---|
Bacillus Clamette-Guerin Vaccine |
1921 |
Diphtheria Toxoid |
1926 |
Tetanus Toxoid |
1933 |
Tetanus and Diphtheria Combined Toxoid |
1934 |
Influenza Vaccine |
1945 |
Pertussis Vaccine |
1949 |
Tetanus, Diphtheria Toxoid and Pertussis Vaccine |
1949 |
Mumps Vaccine, inactivated |
1950 |
Inactivated Poliomyelitis Vaccine (Salk) |
1955 |
Oral Poliomyelitis Vaccine (Sabin) |
1961 |
Trivalent Oral Polio Vaccine |
1963 |
Measles Vaccine, live |
1963 |
Measles Vaccine, inactivated |
1963 |
Mumps Vaccine, live |
1967 |
Rubella Vaccine, live |
1969 |
Measles-Rubella Combined Vaccine, live |
1971 |
Measles-Mumps-Rubella Vaccine, live |
1971 |
Pneumococcal Vaccine (14-valent) |
1977 |
Human Diploid Cell Vaccine (Rabies Vaccine) |
6/80 |
Hepatitis B Vaccine |
11/81 |
Pneumococcal Vaccine (23-valent) |
1983 |
Haemophilus influenzae Type b Polysaccharide Vac. |
4/85 |
Enhanced-Inactivated Poliomyelitis Vaccine |
11/85 |
Hepatitis B Vaccine (RECOMBIVAX HB®) |
7/86 |
IPOLTM |
1987 |
Haemophilus influenzae Type b Conjugate Vaccine |
12/87 |
Diphtheria-Tetanus-Pertussis (Acellular) Vaccine |
12/17/91 (Lederle) 8/21/92 (Connaught) |
Diptheria-Tetanus-Pertusis Haemophilus influenzae Type b Conjugate Combination Vaccine |
3/30/93 |
Hepatitis A Vaccine - 3 dose schedule (SmithKline Beecham) |
2/95 |
Varicella Vaccine |
3/17/95 |
Hepatitis A Vaccine - 2 dose schedule (Merck Vaccine Division) |
3/29/96 |
Diphtheria-Tetanus-Pertussis (Acellular) Vaccine for infants |
7/31/96 (Connaught) |
Diphtheria-Tetanus-Pertussis (Acellular)/ Haemophilus influenzae Type b Conjugate Combination Vaccine (4th dose at 15 to 18 months) |
9/30/96 |
Haemophilus influenzae type b conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant Vaccine) COMVAX |
10/02/96 |
Diptheria & Tetanus Toxoids Adsorbed (Chiron Behring GmbH - with SKB) |
1/29/97 |
Diphtheria-Tetanus-Acellular Pertussis (Infanrix) (Chiron Behring GmbH-with SKB) |
1/29/97 |
Diphtheria & Tetanus Toxoids Adsorbed (Connaught Labs. Ltd) (Children, 6 weeks to 7 years of age). |
4/11/97 |
Rabies Vaccine (Chiron Behring GmbH-Germany) |
10/97 |
Rotavirus Vaccine (Wyeth-Lederle: RotaShield) |
8/31/98 |
Hepatitis B Vaccine - Merck - 5.0 mcg for ages 0-19 years old |
8/98 |
Lyme Vaccine (SmithKline Beecham Biologicals: LYMErix) |
12/21/98 |
Pneumococcal Conjugate Vaccine (Wyeth-Lederle: PrevnarTM) |
2/17/2000 |
SOURCE: U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration
Texas Department of State Health Services, Immunization Branch (as of February 22, 2000).